Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Inventory Average (2019 - 2026)

10x Genomics' Inventory Average history spans 7 years, with the latest figure at $59.1 million for Q4 2025.

  • On a quarterly basis, Inventory Average fell 33.22% to $59.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $59.1 million, a 33.22% decrease, with the full-year FY2025 number at $69.7 million, down 11.07% from a year prior.
  • Inventory Average hit $59.1 million in Q4 2025 for 10x Genomics, down from $65.5 million in the prior quarter.
  • Over the last five years, Inventory Average for TXG hit a ceiling of $91.2 million in Q3 2024 and a floor of $34.2 million in Q1 2021.
  • Historically, Inventory Average has averaged $70.3 million across 5 years, with a median of $76.0 million in 2022.
  • Biggest five-year swings in Inventory Average: soared 103.15% in 2021 and later tumbled 33.22% in 2025.
  • Tracing TXG's Inventory Average over 5 years: stood at $55.6 million in 2021, then soared by 44.24% to $80.1 million in 2022, then dropped by 3.52% to $77.3 million in 2023, then grew by 14.57% to $88.6 million in 2024, then tumbled by 33.22% to $59.1 million in 2025.
  • Business Quant data shows Inventory Average for TXG at $59.1 million in Q4 2025, $65.5 million in Q3 2025, and $71.8 million in Q2 2025.